Results 31 to 40 of about 80,389 (314)

Seasonal incidence of cellulitis in cystic lymphatic malformation and Klippel–Trenaunay syndrome

open access: yesGlobal Pediatrics, 2023
Background: Cellulitis is a common complication of cystic lymphatic malformations (cLM) and Klippel–Trenaunay syndrome (KTS). Cellulitis in the pediatric population requires hospitalization and reduces a patients’ quality of life.
Tamotsu Kobayashi   +9 more
doaj   +1 more source

A case report of exudative retinal detachment derived from orbital cellulitis in mainland China

open access: yesBMC Ophthalmology, 2020
Background Orbital cellulitis is a rare cause of exudative retinal detachment. Hereby, we aimed to report the first case of exudative retinal detachment derived from orbital cellulitis in mainland China.
Wei Song, Cheng Du, Yongjie Zhang
doaj   +1 more source

Genetic stability of Campylobacter coli in patients with primary antibody deficiencies [PDF]

open access: yes, 2019
In the Clinical Communication, Dion et al 1 reported that in patients with severe primary antibody deficiency (PAD), Campylobacter infection is a major cause (6.5%) of chronic or recurrent diarrhea. Moreover, by a molecular study performed in a subset of
Milito, Cinzia, Quinti, Isabella
core   +1 more source

The Cellulitis Season Is Open [PDF]

open access: yesCanadian Journal of Infectious Diseases and Medical Microbiology, 2014
For some infectious diseases specialists, the equivalent of the summer blockbuster was the release of the ‘Practice Guidelines for the Diagnosis and Management of Skin and Soft Tissue Infections’ (SSTI) update on June 18, 2014, by the Infectious Diseases Society of America (IDSA) (1).
Valiquette, Louis, Laupland, Kevin B.
openaire   +6 more sources

Demonstrating the benefit of a cellulitis-specific patient reported outcome measure (CELLUPROM©) as part of the National Cellulitis Improvement Programme in Wales

open access: yesJournal of Patient-Reported Outcomes
Purpose Despite a known risk of cellulitis recurrence, the management of the wider impact and risk factors has been neglected. The innovative National Cellulitis Improvement Programme (NCIP) addresses this by providing evidence-based and individualised ...
Marie Gabe-Walters   +2 more
doaj   +1 more source

Impact of time to first antimicrobial dose on length of stay and 30-day hospital readmission in patients with lower limb cellulitis

open access: yesJournal of Global Antimicrobial Resistance, 2021
: Objectives: There have been efforts to promote timely antimicrobial administration for patients with sepsis, but the importance for other infections is uncertain.
Jaclyn L. Bishop   +10 more
doaj   +1 more source

Feasibility study to inform the design of a UK multi-centre randomised controlled trial of prophylactic antibiotics for the prevention of recurrent cellulitis of the leg [PDF]

open access: yes, 2007
Background: This paper describes the results of a feasibility study for a randomised controlled trial (RCT). Methods: Twenty-nine members of the UK Dermatology Clinical Trials Network (UK DCTN) expressed an interest in recruiting for this study.
Cox, Neil H.   +8 more
core   +1 more source

Comparative Safety Profiles of Ocrelizumab and Rituximab in Multiple Sclerosis Treatment Using Real‐World Evidence

open access: yesAnnals of Neurology, EarlyView.
Objective The objective of this study was to compare the long‐term safety profiles of ocrelizumab and rituximab in persons with multiple sclerosis (MS). Methods Using retrospective data from the University of California (UC) Health System, we simulated a target clinical trial. The primary cohort from UC San Francisco (UCSF) and a validation cohort from
Gabriel Cerono   +3 more
wiley   +1 more source

An interview study to determine the experiences of cellulitis diagnosis amongst health care professionals in the UK

open access: yesBMJ Open, 2020
Objectives To explore healthcare professionals (HCPs) experiences and challenges in diagnosing suspected lower limb cellulitis.Setting UK nationwide.Participants 20 qualified HCPs, who had a minimum of 2 years clinical experience as an HCP in the ...
Joe Kai   +6 more
doaj   +1 more source

Comparative efficacy and safety of anakinra and canakinumab in patients with VEXAS syndrome – an international multicenter study

open access: yesArthritis &Rheumatology, Accepted Article.
Objectives The aim of this study was to compare differences in clinical response, drug survival, and adverse event rates between anakinra and canakinumab in VEXAS syndrome. Methods This multicenter international study includes VEXAS patients from France, Israel, and Italy treated with IL1 inhibition (IL1i).
Tali Eviatar   +35 more
wiley   +1 more source

Home - About - Disclaimer - Privacy